Effects of Sucralfate on Mucositis During and Following Radiotherapy of Malignancies in the Head and Neck Region: A double-blind placebo-controlled study

References

• Dreizen S, Daly T E, Drane J B, Brown L R. Oral complications of cancer radiotherapy. Postgrad Med 1977; 61: 85–92
   PubMed Web of Science ®Google Scholar
• Wescott W B, Mira J G, Starcke E N, Shannon I L, Thornby J I. Alterations in whole saliva flow rate induced by fractionated radiotherapy. Am J Roentgenol 1978; 130: 145–9
   PubMed Web of Science ®Google Scholar
• Mira J G, Wescott W B, Starcke E N, Shannon I L. Some factors influencing salivary function when treating with radiotherapy. Int J Radiat Oncol Biol Phys 1981; 7: 535–41
   PubMed Web of Science ®Google Scholar
• Shannon I L. Management of head and neck irradiated patients. Saliva salivation, T Zelles. Pergamon Press, Oxford 1981; 313–22
   Google Scholar
• Franzén L, Funegård U, Ericsson T, Henriksson R. Parotid gland function and xerostomia during and following radiotherapy of malagnancies in head and neck. Eur J Cancer 1992; 28: 457–62
   PubMed Web of Science ®Google Scholar
• Cheng V ST, Down J, Herbert D, Aramany M. The function of the parotid gland following radiation therapy for head and neck cancer. Int J Radiot Oncol Biol Phys 1981; 7: 253–8
   PubMed Web of Science ®Google Scholar
• Mira J G, Fullerton G D, Wescott W B. Correlation between initial salivary flow rate and radiation dose in production of Xerostomia. Acta Radiol Oncol 1982; 21: 151–4
   PubMed Web of Science ®Google Scholar
• Funegård U, Franzén L, Ericsson T, Henriksson R. Parotid saliva composition during and after irradiation of head and neck cancer. Eur J Oral Cancer., In press.
   Google Scholar
• Bellanti J A, Artenstein M S, Buescher E L. Characterization of virus neutralizing antibodies in human seum and nasal secretions. J Immunol 1965; 94: 344–51
   PubMed Web of Science ®Google Scholar
• Ogra P L, Karzon D T, Rigthand F, McGillivary M. Immunoglobulin response in serum and secretions after immunization with live an inactivated polio vaccine and natural infection. New Eng J Med 1968; 279: 893–900
   PubMed Web of Science ®Google Scholar
• Sirishinka S. Reactions of human salivary immunoglobulins with indigenous bacteria. Arch Oral Biol 1970; 15: 551–4
   Web of Science ®Google Scholar
• Henriksson R, Franzen L, Littbrand B. Does sucralfate reduce radiation-induced diarrhea?. Acta Radiol Oncol 1987; 26: 76–7
   Google Scholar
• Henriksson R, Arevärn M, Franzén L, Persson H, Stendahl U. Beneficial effects of sucralfate in radiation diarrhea. An open randomized study in gynecological cancer patients. Eur J Gynecol Oncol 1990; 4: 299–302
   Google Scholar
• Kochar R, Sharma S C, Gupta B B. Rectal sucralfate in radiation proctitis. Lancet 1988; 2: 400
   Web of Science ®Google Scholar
• Scherlacher A, Beaufort-Spontin F. Strahlentherapie vom Kpof-Hals Malignomen: Entzundungsprophylaxe der Schleimhaut durch Sucralfatbehandlung. HNO 1990; 38: 24–8
   PubMedGoogle Scholar
• Epstein J B, Stevenson-Moore B DS, Jackson S, Mohamed J H, Spinelli J J. Prevention of oral mucositis in radiation therapy: A controlled study with benzydamine hydrochloride rinse. Int J Radiat Oncol Biol Phys 1989; 16: 1571–5
   PubMed Web of Science ®Google Scholar
• Pfeiffer P, Hanse O, Madsen E L. A prospective pilot study on the effect of sucralfate mouth-swishing in reducing stomatitis during radiotherapy of the oral cavity. Acta Oncol 1989; 27: 471–3
   Google Scholar
• Nagashima K. Mechanism of action of sucralfate. J Clin Gastroenterol 1981; 3: 117–23
   PubMed Web of Science ®Google Scholar
• Tamawski A. Sucralfate. Is it more than just a barrier? Cytoprotection—future direction in prevention and treatment of gastrointestinal mucosal injury. Curr Concepts Gastroenterol 1984; 1: 5–8
   Google Scholar
• Henriksson R, Franzén L, Littbrand B. Effects of sucralfate on acute and late gastrointestinal disorders following radiotherapy of pelvic cancer. A double-blind placebo-controlled study. J Clin Oncol 1992; 10: 969–75
   PubMed Web of Science ®Google Scholar
• Cioli V, Corradino C, Scorza-Baracellona P. Review of pahrmacological data on benzydamine. Int J Tissue React 1985; 7: 205–13
   PubMedGoogle Scholar
• Saunders M J, Dische S, Fowler J F. Radiotherapy with three fractions per day for twelve consecutive days for tumors on the thorax, head and neck. Frontiers in radiation therapy and oncology, J M Vaeth, J L Meyers. Karger, BaselSwitzerland 1988; 99–104
   Google Scholar
• Bennet M H, Wilson G D, Dishe S, et al. Tumour proliferation assessed by combined histological and flow cytometric analysis: implications for therapy in squamous cel carcinoma in head and neck. Br J Cancer 1992; 65: 870–8
   PubMed Web of Science ®Google Scholar